1
|
Srinivas NR, Kallem RR, Bartlett MG. Considerations and perspectives on the practice of incurred sample reanalysis assessment for chiral drugs. Biomed Chromatogr 2024; 38:e5954. [PMID: 38962861 DOI: 10.1002/bmc.5954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Accepted: 06/18/2024] [Indexed: 07/05/2024]
Abstract
Given the inherent complexities of bioanalysis, the role of incurred sample reanalysis (ISR) is increasingly appreciated in regulatory bioanalysis. Incurred sample reanalysis has evolved as an integral part of an assay to ensure method reproducibility. The current regulatory ISR guidelines do not provide clarity regarding ISR assessment for chiral drugs comprising enantiomers. Because chiral assays evaluate two enantiomers, there are additional complexities associated with the ISR data generation and interpretation. Based on the current literature, the practices for conducting ISR in chiral methods were reviewed and assessed. While ISR was conducted in chiral methods for both enantiomers using the acceptance criteria prescribed for non-chiral methods, there may be a need to streamline the nuances of ISR data interpretation and define the ISR requirements for chiral methods. The article provides perspectives on the ISR of enantiomeric drugs, including strategy development, by providing various hypothetical scenarios and possible considerations for defining ISR evaluation for chiral assays.
Collapse
Affiliation(s)
- Nuggehally R Srinivas
- Department of Clinical Pharmacology and Pharmacometrics, Longboard Pharmaceuticals, La Jolla, California, USA
| | - Raja Reddy Kallem
- Department of Clinical Pharmacology and Pharmacometrics, Longboard Pharmaceuticals, La Jolla, California, USA
| | - Michael G Bartlett
- Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA
| |
Collapse
|
2
|
Dong L, Li K, Gao S, Wang W, Feng Y, Zhang J, Yang J, Dong W, Zhang W. Sensitive and effective method with 96-well plate for determination of levamlodipine in human plasma using LC-MS/MS. Anal Biochem 2024; 691:115556. [PMID: 38705226 DOI: 10.1016/j.ab.2024.115556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2024] [Revised: 05/01/2024] [Accepted: 05/02/2024] [Indexed: 05/07/2024]
Abstract
we developed an effective protein precipitation method for determination of levamlodipine in human plasma using LC-MS/MS. Sample extraction was carried out by using liquid-liquid extraction in 96-well plate format. (S)-Amlodipine-d4 was used as internal standard (IS). The chromatographic separation was achieved using Philomen Chiral MX (2) column (3 μm, 2.1 × 100 mm). Mobile phase A was comprised of Acetonitrile (ACN), Mono ethanol amine (MEA) and Iso-Propyl alcohol (IPA) (1000:1:10, v/v/v), Mobile phase B was IPA-ACN (2:1, v/v). The flow rate was 0.4 mL/min. The total run time of each sample was 4.0 min with gradient elution. LC-MS/MS spectra were generated in positive ion mode, and multiple reaction monitoring (MRM) was used to detect the following transitions: m/z 409.20 → 238.15 for levamlodipine and 415.25 → 240.20 for (S)-Amlodipine-d4 (the IS). The method was linear from 50 to 10000 pg/mL(R2=0.9988489),and the lower limit of quantification (LLOQ) was 50 pg/mL. This method was applied to a bioequivalence study of levamlodipine.
Collapse
Affiliation(s)
- Lingfang Dong
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Kun Li
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Shan Gao
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Wenyi Wang
- Department of Day Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Yinghua Feng
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Jingying Zhang
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Jie Yang
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China
| | - Weifeng Dong
- Suzhou Guochen Biotechnology Co., Ltd., Jiangsu, 215000, China
| | - Wei Zhang
- Department of Pharmacy, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
| |
Collapse
|
3
|
Sun DM, Zhang Y, Zhou Y, Feng XS, Zhang XY. Progress of Pretreatment and Analytical Methods of Proton Pump Inhibitors: An Update since 2010. Crit Rev Anal Chem 2023:1-26. [PMID: 36654243 DOI: 10.1080/10408347.2023.2166782] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
Proton pump inhibitors (PPIs) are the most commonly used medication for stomach secretion disorders. However, when it comes to safe, discreet pharmaceutical practice, widely recognized preparational and analytical method(s) for PPIs with sensitivity, selectivity, speed and high accuracy still remains underdeveloped. For this reason, this paper sets out to make a comprehensive review of the preparation and determination methods for PPIs based on multiple matrices since 2010. We have integrated newly-developed techniques (such as solid phase extraction, liquid phase micro-extraction, and solid phase micro-extraction) into conventional sample preparational methods. On the other hand, our analytical techniques include liquid chromatography, supercritical fluid chromatography, capillary electrophoresis, and employment of sensors. In addition, we have identified the pros and cons of each technique and have forecast their future developmental trends.
Collapse
Affiliation(s)
- De-Mei Sun
- School of Pharmacy, China Medical University, Shenyang, China
| | - Yuan Zhang
- School of Pharmacy, China Medical University, Shenyang, China
| | - Yu Zhou
- Department of Pharmacy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Xue-Song Feng
- School of Pharmacy, China Medical University, Shenyang, China
| | - Xin-Yuan Zhang
- School of Forensic Medicine, China Medical University, Shenyang, China
| |
Collapse
|
4
|
Papp LA, Hancu G, Kelemen H, Tóth G. Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview. Electrophoresis 2021; 42:1761-1789. [PMID: 34004039 DOI: 10.1002/elps.202100032] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 04/27/2021] [Accepted: 05/05/2021] [Indexed: 11/08/2022]
Abstract
Proton pump inhibitors (PPIs) are benzimidazole-derivative chiral sulfoxides, frequently used in the treatment of gastric hyperacidity-related disorders. Due to their stereoselective metabolism, the eutomeric forms of PPIs can present a more advantageous pharmacokinetic profile by comparison with the distomers or racemates. Moreover, two representatives of the class are used in therapy both as racemates and as pure enantiomers (esomeprazole, dexlansoprazole). A relatively large number of enantioseparation methods employed for the stereoselective determination of PPIs from pharmaceutical, biological, and environmental matrices were published in the past three decades. The purpose of the current overview is to provide a systematic survey of the available chiral separation methods published since the introduction of PPIs in the therapy up to the present. Analytical and bioanalytical methods using different chromatographic and electromigration techniques reported for the enantioseparation of omeprazole, lansoprazole, pantoprazole, rabeprazole, ilaprazole, and tenatoprazole are included. The analytical conditions of the presented methods are summarized in three comprehensive tables, while a critical discussion of the applied techniques, possible mechanism of enantiorecognition, and future perspectives on the topic are also presented.
Collapse
Affiliation(s)
- Lajos Attila Papp
- Department of Pharmaceutical Chemistry, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureș, Romania
| | - Gabriel Hancu
- Department of Pharmaceutical Chemistry, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureș, Romania
| | - Hajnal Kelemen
- Department of Pharmaceutical Chemistry, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureș, Romania
| | - Gergő Tóth
- Department of Pharmaceutical Chemistry, Semmelweis University, Budapest, Hungary
| |
Collapse
|
5
|
Liu M, Zhang J, Dong L, Xue W, He Q, Liang W, Liu X, Zhang J, Gu L, Feng Y, Yang J, Wang H, Wang Y, Li K, Li Y, Kong W, Zhang X, Yao M, Wang K, Ma P, Zhang W. Detection of sivelestat and its metabolite in small volumes of plasma from Chinese ALI/ARDS patients with SIRS via high-throughput UPLC-MS/MS: A pharmacokinetic study. J Pharm Biomed Anal 2020; 195:113876. [PMID: 33429252 PMCID: PMC7833710 DOI: 10.1016/j.jpba.2020.113876] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Revised: 12/15/2020] [Accepted: 12/26/2020] [Indexed: 01/08/2023]
Abstract
In this study, we developed a sensitive and efficient analytical approach combining a 96-well plate-based protein precipitation strategy with ultra-performance liquid chromatography electrospray ionization tandem mass spectrometry (UPLC-MS/MS) in order to assess the pharmacokinetic (PK) properties of sivelestat and its metabolite XW-IMP-A in samples of plasma from ALI/ARDS patients with SIRS. The samples were separated via gradient elution with a C18 column (Phenomenex Kinetex, C18, 2.6 μm, 100 Å, 50 × 2.1 mm) using 0.1 % formic acid aqueous solution (A) and acetonitrile-methanol (1:1, V:V) (B) as a mobile phase at a 0.6 mL/min flow rate. UPLC-MS/MS spectra were generated in positive ion mode, and multiple reaction monitoring (MRM) was used to detect the following transitions: m/z 435.1 → 360.0 for sivelestat, m/z 469.0 → 394.0 for sivelestat-IS, m/z 351.0 → 276.0 for XW-IMP-A, and m/z 384.9 → 310.0 for XW-IMP-A-IS. This assay was run for 2.5 min in total, and achieved lowest limit of quantitation values of 2.0 ng/mL and 0.5 ng/mL for sivelestat and XW-IMP-A, respectively, while remaining highly linear from 2-500 ng/mL for sivelestat (r2 ≥ 0.9900) and from 0.5-125 ng/mL for XW-IMP-A (r2 ≥ 0.9900). These validated data were consistent with US Food and Drug Administration (FDA) and European Medicines Agency (EMA) acceptance criteria. In addition, this method was successfully applied to the steady-state PK evaluation of ALI/ARDS patients with SIRS.
Collapse
Affiliation(s)
- Mingzhou Liu
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China.
| | - Jing Zhang
- Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Lingfang Dong
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Wenhua Xue
- Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China
| | - Qilin He
- WuXi AppTec (Shanghai) Co., Ltd, Shanghai, China
| | | | - Xing Liu
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Jingying Zhang
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Li Gu
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Yinghua Feng
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Jie Yang
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Haibo Wang
- Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Yaqin Wang
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Kun Li
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Yuanlong Li
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China
| | - Weiqin Kong
- Umins (Wuhan) Pharmaceutical Co., Ltd, Wuhan, Hubei, 430000, China
| | - Xiaojian Zhang
- Department of Respiratory and Critical Care Unit, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
| | - Mengying Yao
- Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
| | - Kai Wang
- Department of Respiratory and Critical Care Medicine, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China.
| | - Peizhi Ma
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China.
| | - Wei Zhang
- Department of Pharmacy, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, 450003, China.
| |
Collapse
|
6
|
Sun L, Zhang Y, Yang Y, Shen Y, Ying Y, Su Y, Zhang X, Liu Y, Huang X, Wang Y. Simultaneous enantioselective determination of omeprazole, rabeprazole, lansoprazole, and pantoprazole enantiomers in human plasma by chiral liquid chromatography–tandem mass spectrometry. J Sep Sci 2020; 43:3183-3196. [PMID: 32495501 DOI: 10.1002/jssc.202000226] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2020] [Revised: 05/29/2020] [Accepted: 05/30/2020] [Indexed: 12/31/2022]
Affiliation(s)
- Lu‐Ning Sun
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
| | - Ye Zhang
- Department of PharmacyNanjing Jinling Hospital Nanjing P. R. China
| | - Yu‐Qing Yang
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
| | - Ye Shen
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
| | - Yu‐Wen Ying
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
| | - Yu‐Wen Su
- School of PharmacyNanjing Medical University Nanjing P. R. China
| | - Xue‐Hui Zhang
- Department of PharmacyJiangsu Shengze Hospital Suzhou P. R. China
| | - Yun Liu
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
| | - Xu Huang
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
| | - Yong‐Qing Wang
- Research Division of Clinical PharmacologyFirst Affiliated Hospital of Nanjing Medical University Nanjing P. R. China
- Department of PharmacyJiangsu Shengze Hospital Suzhou P. R. China
| |
Collapse
|
7
|
Jiao H, Li Y, Sun L, Zhang H, Yu L, Yu L, Yuan Z, Xie L, Chen J, Wang Y. A chiral LC-MS/MS method for the enantioselective determination of R
-(+)- and S
-(-)-pantoprazole in human plasma and its application to a pharmacokinetic study of S
-(-)-pantoprazole sodium injection. Biomed Chromatogr 2017; 31. [PMID: 28370240 DOI: 10.1002/bmc.3980] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2017] [Revised: 03/16/2017] [Accepted: 03/26/2017] [Indexed: 12/12/2022]
Affiliation(s)
- Huiwen Jiao
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Yueqi Li
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Luning Sun
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Hongwen Zhang
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Liyuan Yu
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Lei Yu
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Ziqingyun Yuan
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Lijun Xie
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Juan Chen
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
| | - Yongqing Wang
- Research Division of Clinical Pharmacology, First Affiliated Hospital; Nanjing Medical University; Nanjing China
- Department of Pharmacy, Jiangsu Shengze Hospital; Nanjing Medical University; Suzhou China
| |
Collapse
|